- 4-Week # shares sold: 2,000
- 12-Week # shares sold: 2,000
- 24-Week # shares sold: 13,250
The squeeze is on these stocks, and they are poised for volatile moves.
Despite tepid market reaction, and analyst skepticism, there might be some upside for TMO.
Thermo Fisher Scientific (TMO) has reportedly offered $30 billion to acquire Illumina (ILMN).